Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
3
×
Tags
biotech
detroit blog main
detroit top stories
3
×
fda
life sciences
national blog main
biogen
boston blog main
boulder/denver blog main
boulder/denver top stories
cancer
clinical trials
deerfield management
europe blog main
europe top stories
gilead sciences
indiana blog main
indiana top stories
ipo
melinta therapeutics
national
national top stories
new york blog main
new york top stories
novartis
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
startups
texas blog main
texas top stories
venture capital
wisconsin blog main
wisconsin top stories
abbvie
What
medicines
3
×
bio
covid
fda
ipo
roundup
acquisitions
activity
announced
approvals
approved
biogen
ceo
cholesterol
clamped
collabs
combo
daniel
deal
delays
developing
drug
economic
esperion
esperion’s
fast
gilead
gilead’s
help
including
introduce
isn’t
levels
lot
lowering
month
new
nod
oric’s
o’day
Language
unset
3
×
Current search:
medicines
×
unset
×
" detroit top stories "
×
photo
×
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Esperion’s Combo Pill for Lowering Cholesterol Levels Wins FDA Nod